Rajeev Subramanyam1, Robert Fleck2, John McAuliffe3, Rupa Radhakrishnan2, Dorothy Jung2, Mario Patino3, Mohamed Mahmoud3. 1. Department of Anesthesia, Cincinnati Children's Hospital Medical Center, OH, USA. Electronic address: Rajeev.Subramanyam@cchmc.org. 2. Department of Radiology, Cincinnati Children's Hospital Medical Center, OH, USA. 3. Department of Anesthesia, Cincinnati Children's Hospital Medical Center, OH, USA.
Abstract
BACKGROUND AND OBJECTIVES: Children with Down Syndrome are vulnerable to significant upper airway obstruction due to relative macroglossia and dynamic airway collapse. The objective of this study was to compare the upper airway dimensions of children with Down Syndrome and obstructive sleep apnea with normal airway under dexmedetomidine sedation. METHODS: IRB approval was obtained. In this retrospective study, clinically indicated dynamic sagittal midline magnetic resonance images of the upper airway were obtained under low (1mcg/kg/h) and high (3mcg/kg/h) dose dexmedetomidine. Airway anteroposterior diameters and sectional areas were measured as minimum and maximum dimensions by two independent observers at soft palate (nasopharyngeal airway) and at base of the tongue (retroglossal airway). RESULTS AND CONCLUSIONS: Minimum anteroposterior diameter and minimum sectional area at nasopharynx and retroglossal airway were significantly reduced in Down Syndrome compared to normal airway at both low and high dose dexmedetomidine. However, there were no significant differences between low and high dose dexmedetomidine in both Down Syndrome and normal airway. The mean apnea hypopnea index in Down Syndrome was 16±11. Under dexmedetomidine sedation, children with Down Syndrome and obstructive sleep apnea when compared to normal airway children show significant reductions in airway dimensions most pronounced at the narrowest points in the nasopharyngeal and retroglossal airways.
BACKGROUND AND OBJECTIVES:Children with Down Syndrome are vulnerable to significant upper airway obstruction due to relative macroglossia and dynamic airway collapse. The objective of this study was to compare the upper airway dimensions of children with Down Syndrome and obstructive sleep apnea with normal airway under dexmedetomidine sedation. METHODS: IRB approval was obtained. In this retrospective study, clinically indicated dynamic sagittal midline magnetic resonance images of the upper airway were obtained under low (1mcg/kg/h) and high (3mcg/kg/h) dose dexmedetomidine. Airway anteroposterior diameters and sectional areas were measured as minimum and maximum dimensions by two independent observers at soft palate (nasopharyngeal airway) and at base of the tongue (retroglossal airway). RESULTS AND CONCLUSIONS: Minimum anteroposterior diameter and minimum sectional area at nasopharynx and retroglossal airway were significantly reduced in Down Syndrome compared to normal airway at both low and high dose dexmedetomidine. However, there were no significant differences between low and high dose dexmedetomidine in both Down Syndrome and normal airway. The mean apnea hypopnea index in Down Syndrome was 16±11. Under dexmedetomidine sedation, children with Down Syndrome and obstructive sleep apnea when compared to normal airway children show significant reductions in airway dimensions most pronounced at the narrowest points in the nasopharyngeal and retroglossal airways.
Authors: Rosemary S C Horne; Ashwini Sakthiakumaran; Ahmad Bassam; Julie Thacker; Lisa M Walter; Margot J Davey; Gillian M Nixon Journal: Pediatr Res Date: 2020-11-23 Impact factor: 3.756
Authors: Christy R Sibarani; Lisa M Walter; Margot J Davey; Gillian M Nixon; Rosemary S C Horne Journal: Pediatr Res Date: 2021-07-06 Impact factor: 3.756
Authors: Elisa Fucà; Floriana Costanzo; Laura Celestini; Alessandra Mandarino; Stefano Vicari Journal: Int J Environ Res Public Health Date: 2021-05-09 Impact factor: 3.390